Senator Brownback affirms the existence of a solvency problem.
04/20/2009
https://www.congress.gov...
Less than 3 percent of the rare diseases have an FDA-approved treatment.
Does this make any sense? Where is the cost-benefit analysis?
I am very pleased that the President set the November timeframe to address outstanding issues on the U.S.-South Korean F...
I will guarantee you----